L. Seeff, Natural history of chronic hepatitis C, Hepatology, vol.349, issue.S1, pp.35-46, 2002.
DOI : 10.1002/hep.1840360706

M. Alter, Epidemiology of viral hepatitis and HIV co-infection, Journal of Hepatology, vol.44, pp.6-9, 2006.
DOI : 10.1016/j.jhep.2005.11.004

D. Lavanchy, Evolving epidemiology of hepatitis C virus, Clinical Microbiology and Infection, vol.17, issue.2, pp.107-115, 2011.
DOI : 10.1111/j.1469-0691.2010.03432.x

J. Perz, G. Armstrong, L. Farrington, Y. Hutin, and B. Bell, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, Journal of Hepatology, vol.45, issue.4, pp.529-538, 2006.
DOI : 10.1016/j.jhep.2006.05.013

M. Manns, H. Wedemeyer, and M. Cornberg, Treating viral hepatitis C: efficacy, side effects, and complications, Gut, vol.55, issue.9, pp.1350-1359, 2006.
DOI : 10.1136/gut.2005.076646
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860034

C. Sarrazin, C. Hézode, S. Zeuzem, and J. Pawlotsky, Antiviral strategies in hepatitis C virus infection, Journal of Hepatology, vol.56, issue.1, pp.88-100, 2012.
DOI : 10.1016/S0168-8278(12)60010-5

B. Edlin, Perspective: Test and treat this silent killer, Nature, vol.46, issue.7350_supp, pp.18-19, 2011.
DOI : 10.1038/474S18a
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751873

P. Simmonds, J. Bukh, C. Combet, G. Deléage, N. Enomoto et al., Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes, Hepatology, vol.17, issue.4, pp.962-973, 2005.
DOI : 10.1002/hep.20819
URL : https://hal.archives-ouvertes.fr/hal-00313678

K. Dowd, D. Netski, X. Wang, A. Cox, and S. Ray, Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus, Gastroenterology, vol.136, issue.7, pp.2377-2386, 2009.
DOI : 10.1053/j.gastro.2009.02.080

L. Liu, B. Fisher, K. Dowd, J. Astemborski, A. Cox et al., Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection, Journal of Virology, vol.84, issue.10, pp.5067-5077, 2010.
DOI : 10.1128/JVI.02265-09

M. Lucas, A. Ulsenheimer, K. Pfafferot, M. Heeg, S. Gaudieri et al., Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection, PLoS ONE, vol.201, issue.7, p.649, 2007.
DOI : 10.1371/journal.pone.0000649.t003

R. Lanford, B. Guerra, D. Chavez, C. Bigger, K. Brasky et al., Cross-Genotype Immunity to Hepatitis C Virus, Journal of Virology, vol.78, issue.3, pp.1575-1581, 2004.
DOI : 10.1128/JVI.78.3.1575-1581.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC321392

W. Osburn, B. Fisher, K. Dowd, G. Urban, L. Liu et al., Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection, Gastroenterology, vol.138, issue.1, pp.315-324, 2010.
DOI : 10.1053/j.gastro.2009.09.017

L. Alvarez-lajonchere and S. Dueñas-carrera, Complete Definition of Immunological Correlates of Protection and Clearance of Hepatitis C Virus Infection: A Relevant Pending Task for Vaccine Development, International Reviews of Immunology, vol.100, issue.10, pp.223-242, 2012.
DOI : 10.4161/hv.5.3.6614

G. Missale, R. Bertoni, V. Lamonaca, A. Valli, M. Massari et al., Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response., Journal of Clinical Investigation, vol.98, issue.3, p.706, 1996.
DOI : 10.1172/JCI118842

G. Pape, T. Gerlach, H. Diepolder, N. Grüner, M. Jung et al., Role of the specific T-cell response for clearance and control of hepatitis C virus, Journal of Viral Hepatitis, vol.6, issue.s1, pp.36-40, 1999.
DOI : 10.1016/S0140-6736(95)91992-9

J. Schulze-zur-wiesch, D. Ciuffreda, L. Lewis-ximenez, V. Kasprowicz, B. Nolan et al., T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence, The Journal of Experimental Medicine, vol.160, issue.1, pp.61-75, 2012.
DOI : 10.1053/jhep.2003.50115

N. Shoukry, A. Grakoui, M. Houghton, D. Chien, J. Ghrayeb et al., T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection, The Journal of Experimental Medicine, vol.2, issue.12, pp.1645-1655, 2003.
DOI : 10.1038/nri779
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193956

M. Puig, K. Mihalik, J. Tilton, O. Williams, M. Merchlinsky et al., CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus, Hepatology, vol.169, issue.3, pp.736-745, 2006.
DOI : 10.1002/hep.21319

J. Pestka, M. Zeisel, E. Bläser, P. Schürmann, B. Bartosch et al., Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, p.6025, 2007.
DOI : 10.1073/pnas.0607026104
URL : https://hal.archives-ouvertes.fr/inserm-00395910

S. Raghuraman, H. Park, W. Osburn, E. Winkelstein, B. Edlin et al., Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion, Journal of Infectious Diseases, vol.205, issue.5, pp.763-771, 2012.
DOI : 10.1093/infdis/jir835

D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier et al., Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.10, pp.6023-6034, 2005.
DOI : 10.1128/JVI.79.10.6023-6034.2005

C. Logvinoff, M. Major, D. Oldach, S. Heyward, A. Talal et al., Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.101, issue.27, p.10149, 2004.
DOI : 10.1073/pnas.0403519101
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC454180

F. Roohvand and N. Kossari, Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine design, Expert Opinion on Therapeutic Patents, vol.17, issue.20, pp.1811-1830, 2011.
DOI : 10.1038/nature08463

T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto et al., Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-796, 2005.
DOI : 10.1002/jmv.10297

M. Houghton, Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses, Immunological Reviews, vol.436, issue.Suppl., pp.99-108, 2011.
DOI : 10.1111/j.1600-065X.2010.00977.x

S. Feinstone, D. Hu, and M. Major, Prospects for Prophylactic and Therapeutic Vaccines Against Hepatitis C Virus, Clinical Infectious Diseases, vol.55, issue.suppl 1, pp.25-32, 2012.
DOI : 10.1093/cid/cis362

F. Roohvand and N. Kossari, Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities, Expert Opinion on Therapeutic Patents, vol.24, issue.4, pp.391-415, 2012.
DOI : 10.4161/hv.7.3.14303

J. Torresi, D. Johnson, and H. Wedemeyer, Progress in the development of preventive and therapeutic vaccines for hepatitis C virus, Journal of Hepatology, vol.54, issue.6, pp.1273-1285, 2011.
DOI : 10.1016/j.jhep.2010.09.040

Q. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien et al., Vaccination of chimpanzees against infection by the hepatitis C virus., Proceedings of the National Academy of Sciences, vol.91, issue.4, p.1294, 1994.
DOI : 10.1073/pnas.91.4.1294

M. Houghton and S. Abrignani, Prospects for a vaccine against the hepatitis C virus, Nature, vol.5, issue.7053, pp.961-966, 2005.
DOI : 10.1056/NEJMoa051016

S. Frey, M. Houghton, S. Coates, S. Abrignani, D. Chien et al., Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults, Vaccine, vol.28, issue.38, pp.6367-6373, 2010.
DOI : 10.1016/j.vaccine.2010.06.084

R. Ray, K. Meyer, A. Banerjee, A. Basu, S. Coates et al., Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins, The Journal of Infectious Diseases, vol.202, issue.6, pp.862-866, 2010.
DOI : 10.1086/655902

H. Dahari, S. Feinstone, and M. Major, Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins, Gastroenterology, vol.139, issue.3, pp.965-974, 2010.
DOI : 10.1053/j.gastro.2010.05.077

M. Law, T. Maruyama, J. Lewis, E. Giang, A. Tarr et al., Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge, Nature Medicine, vol.78, issue.1, pp.25-27, 2007.
DOI : 10.1016/j.virol.2006.05.015

E. Giang, M. Dorner, J. Prentoe, M. Dreux, M. Evans et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus, Proceedings of the National Academy of Sciences, vol.109, issue.16, pp.6205-6210, 2012.
DOI : 10.1073/pnas.1114927109

J. Meunier, R. Russell, V. Goossens, S. Priem, H. Walter et al., Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus, Journal of Virology, vol.82, issue.2, pp.966-973, 2007.
DOI : 10.1128/JVI.01872-07

Z. Keck, V. Sung, S. Perkins, R. J. Paul, S. Liang et al., Human Monoclonal Antibody to Hepatitis C Virus E1 Glycoprotein That Blocks Virus Attachment and Viral Infectivity, Journal of Virology, vol.78, issue.13, pp.7257-7263, 2004.
DOI : 10.1128/JVI.78.13.7257-7263.2004

R. Ralston, K. Thudium, K. Berger, C. Kuo, B. Gervase et al., Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses, J Virol, vol.67, pp.6753-6761, 1993.

S. Duvet, L. Cocquerel, A. Pillez, R. Cacan, A. Verbert et al., Hepatitis C Virus Glycoprotein Complex Localization in the Endoplasmic Reticulum Involves a Determinant for Retention and Not Retrieval, Journal of Biological Chemistry, vol.273, issue.48, p.32088, 1998.
DOI : 10.1074/jbc.273.48.32088

I. Sominskaya, E. Alekseeva, D. Skrastina, V. Mokhonov, E. Starodubova et al., Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene, Molecular Immunology, vol.43, issue.12, pp.1941-1952, 2006.
DOI : 10.1016/j.molimm.2005.11.018

G. Leroux-roels, A. Batens, I. Desombere, B. Van-den-steen, V. Stichele et al., Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection, Human Vaccines, vol.1, issue.2, pp.61-65, 2005.
DOI : 10.4161/hv.1.2.1554

W. Mcaleer, E. Buynak, R. Maigetter, D. Wampler, W. Miller et al., Human hepatitis B vaccine from recombinant yeast, Nature, vol.117, issue.5947, pp.178-180, 1984.
DOI : 10.1038/307178a0

. Safety, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24?45 years: a randomised, double-blind trial, Lancet, vol.373, pp.1949-1957, 2009.

T. Baumert, S. Ito, D. Wong, and T. Liang, Hepatitis C virus structural proteins assemble into viruslike particles in insect cells, J Virol, vol.72, pp.3827-3836, 1998.

T. Baumert, J. Vergalla, J. Satoi, M. Thomson, M. Lechmann et al., Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate, Gastroenterology, vol.117, issue.6, pp.1397-1407, 1999.
DOI : 10.1016/S0016-5085(99)70290-8

M. Triyatni, J. Vergalla, A. Davis, K. Hadlock, S. Foung et al., Structural Features of Envelope Proteins on Hepatitis C Virus-like Particles as Determined by Anti-envelope Monoclonal Antibodies and CD81 Binding, Virology, vol.298, issue.1, pp.124-132, 2002.
DOI : 10.1006/viro.2002.1463

M. Lechmann, Hepatitis C virus???like particles induce virus-specific humoral and cellular immune responses in mice, Hepatology, vol.34, issue.2, pp.417-423, 2001.
DOI : 10.1053/jhep.2001.26523

S. Jeong, M. Qiao, M. Nascimbeni, Z. Hu, B. Rehermann et al., Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates, Journal of Virology, vol.78, issue.13, pp.6995-7003, 2004.
DOI : 10.1128/JVI.78.13.6995-7003.2004

K. Murata, M. Lechmann, M. Qiao, T. Gunji, H. Alter et al., Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection, Proceedings of the National Academy of Sciences, vol.100, issue.11, pp.6753-6758, 2003.
DOI : 10.1073/pnas.1131929100

G. Elmowalid, M. Qiao, S. Jeong, B. Borg, T. Baumert et al., Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees, Proceedings of the National Academy of Sciences, vol.104, issue.20, pp.8427-8432, 2007.
DOI : 10.1073/pnas.0702162104

B. Bartosch, J. Dubuisson, and F. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003.
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783

C. Ludwig and R. Wagner, Virus-like particles???universal molecular toolboxes, Current Opinion in Biotechnology, vol.18, issue.6, pp.537-545, 2007.
DOI : 10.1016/j.copbio.2007.10.013

B. Bartosch, J. Bukh, J. Meunier, C. Granier, R. Engle et al., In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.14199-14204, 2003.
DOI : 10.1073/pnas.2335981100

P. Garrone, A. Fluckiger, P. Mangeot, E. Gauthier, P. Dupeyrot-lacas et al., A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques, Science Translational Medicine, vol.3, issue.94, pp.94-71, 2011.
DOI : 10.1126/scitranslmed.3002330

C. Huret, D. Desjardins, M. Miyalou, B. Levacher, A. Zin et al., Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice, Vaccine, vol.31, issue.11, pp.1540-1547, 2013.
DOI : 10.1016/j.vaccine.2012.05.025

M. Mihailova, M. Boos, I. Petrovskis, V. Ose, D. Skrastina et al., Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV), Vaccine, vol.24, issue.20
DOI : 10.1016/j.vaccine.2006.02.051

I. Sominskaya, D. Skrastina, A. Dislers, D. Vasiljev, M. Mihailova et al., Construction and Immunological Evaluation of Multivalent Hepatitis B Virus (HBV) Core Virus-Like Particles Carrying HBV and HCV Epitopes, Clinical and Vaccine Immunology, vol.17, issue.6, pp.1027-1033, 2010.
DOI : 10.1128/CVI.00468-09

I. Lee, C. Kim, and W. Ryu, Presentation of the hydrophilic domains of hepatitis C Viral E2 envelope glycoprotein on hepatitis B surface antigen particles, Journal of Medical Virology, vol.62, issue.2, pp.145-151, 1996.
DOI : 10.1002/(SICI)1096-9071(199610)50:2<145::AID-JMV7>3.0.CO;2-A

H. Netter, T. Macnaughton, W. Woo, R. Tindle, and E. Gowans, Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes, Journal of Virology, vol.75, issue.5, pp.2130-2141, 2001.
DOI : 10.1128/JVI.75.5.2130-2141.2001

P. Vietheer, I. Boo, H. Drummer, and H. Netter, Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies

R. Patient, C. Hourioux, P. Vaudin, J. Pagès, and P. Roingeard, Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies, New Biotechnology, vol.25, issue.4, pp.226-234, 2009.
DOI : 10.1016/j.nbt.2009.01.001
URL : https://hal.archives-ouvertes.fr/inserm-00380276

E. Beaumont, R. Patient, C. Hourioux, I. Dimier-poisson, and P. Roingeard, Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine, Hepatology, vol.8, issue.Suppl 1, pp.1303-1313, 2013.
DOI : 10.1002/hep.26132
URL : https://hal.archives-ouvertes.fr/inserm-00812948

J. Denis, N. Majeau, E. Acosta-ramirez, C. Savard, M. Bedard et al., Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization, Virology, vol.363, issue.1, pp.59-68, 2007.
DOI : 10.1016/j.virol.2007.01.011

M. Michel, M. Mancini, E. Sobczak, V. Favier, D. Guetard et al., Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles., Proceedings of the National Academy of Sciences, vol.85, issue.21, p.7957, 1988.
DOI : 10.1073/pnas.85.21.7957

I. Berkower, A. Spadaccini, H. Chen, D. Al-awadi, J. Muller et al., Hepatitis B virus surface antigen assembly function persists when entire transmembrane domains 1
DOI : 10.1128/jvi.02061-10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067800

S. Phogat, K. Svehla, M. Tang, A. Spadaccini, J. Muller et al., Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles, Virology, vol.373, issue.1, pp.72-84, 2008.
DOI : 10.1016/j.virol.2007.11.005

G. Strickland, S. El-kamary, P. Klenerman, and A. Nicosia, Hepatitis C vaccine: supply and demand, The Lancet Infectious Diseases, vol.8, issue.6, pp.379-386, 2008.
DOI : 10.1016/S1473-3099(08)70126-9

A. Folgori, S. Capone, L. Ruggeri, A. Meola, E. Sporeno et al., A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, vol.35, issue.2, pp.190-197, 2006.
DOI : 10.1038/nm1353

E. Barnes, A. Folgori, S. Capone, L. Swadling, S. Aston et al., Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man, Science Translational Medicine, vol.4, issue.115
DOI : 10.1126/scitranslmed.3003155